Impact of earlyvslate postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer
Author:
Affiliation:
1. Department of Endocrinology, Diabetes and Metabolism; Evangelismos Hospital; Athens Greece
2. Department of Nuclear Medicine; Evangelismos Hospital; Athens Greece
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Reference31 articles.
1. The management of thyroid cancer in adults: a review of new guidelines;Harris;Clinical medicine (London, England),2002
2. Use of radioactive iodine for thyroid cancer;Haymart;JAMA,2011
3. Increasing incidence of thyroid cancer in the United States, 1973-2002;Davies;JAMA,2006
4. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005;Chen;Cancer,2009
5. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients;Hay;World Journal of Surgery,2002
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ablation rates and long term outcome following low dose radioiodine for differentiated thyroid cancer in the West of Scotland: a retrospective analysis;Endocrine Practice;2024-01
2. Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer;Hormone and Metabolic Research;2023-06-02
3. Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer;The Journal of Clinical Endocrinology & Metabolism;2023-05-11
4. Present and future of target therapies and theranostics: refining traditions and exploring new frontiers—highlights from annals of Nuclear Medicine 2021;European Journal of Nuclear Medicine and Molecular Imaging;2022-07-23
5. Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study and a meta‐analysis;Cancer Medicine;2022-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3